CytoDyn (CYDY) Non-Current Assets (2011 - 2026)
CytoDyn's Non-Current Assets came in at $95,000 for fiscal Q4 2026 (quarter ended May 31, 2026), down 43.8% from $169,000 a year earlier but up 61.0% from the prior quarter.
CytoDyn (CYDY) Non-Current Assets (2011 - 2026) Analysis & Trends
Going back to fiscal Q4 2011, CytoDyn's Non-Current Assets data covers 61 quarters.
- Non-Current Assets has declined in each of the last five fiscal years, with a five-year compound annual growth rate of -74.9% (FY2021 to FY2026).
- Going back by fiscal year, Non-Current Assets was $169,000 in FY2025 (-47.4%), $321,000 in FY2024 (-34.1%), $487,000 in FY2023 (-97.4%) and $18.67 million in FY2022 (-80.5%).
- The five-year range for quarterly Non-Current Assets is $59,000 (fiscal Q3 2026) to $18.67 million (fiscal Q4 2022).
- Year-over-year, Non-Current Assets has declined for 15 consecutive quarters, with an average decline of 49.2% over the last eight quarters.
- The fastest year-over-year change in Non-Current Assets over five years came in fiscal Q1 2023 (growth of 748.8%), and the weakest in fiscal Q1 2024 (a decline of 97.6%).
- Business Quant data shows CYDY's Non-Current Assets at $59,000 (Q3 2026), $96,000 (Q2 2026) and $133,000 (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | CytoDyn | 340.03 Mn | 291.18 Mn | - | 71,000.00 |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 71,000.00 |
| May 31, 2026 | 95,000.00 |
| Feb 28, 2026 | 59,000.00 |
| Nov 30, 2025 | 96,000.00 |
| Aug 31, 2025 | 133,000.00 |
| May 31, 2025 | 169,000.00 |
| Feb 28, 2025 | 207,000.00 |
| Nov 30, 2024 | 244,000.00 |
| Aug 31, 2024 | 283,000.00 |
| May 31, 2024 | 321,000.00 |
| Feb 29, 2024 | 360,000.00 |
| Nov 30, 2023 | 400,000.00 |
| Aug 31, 2023 | 443,000.00 |
| May 31, 2023 | 487,000.00 |
| Feb 28, 2023 | 532,000.00 |
| Nov 30, 2022 | 523,000.00 |
| Aug 31, 2022 | 18.54 Mn |
| May 31, 2022 | 18.67 Mn |
| Feb 28, 2022 | 1.73 Mn |
| Nov 30, 2021 | 1.89 Mn |
CytoDyn Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=CYDY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();